1. P1104: A PHASE 1 STUDY EVALUATING SAFETY AND EFFICACY OF PARSACLISIB IN COMBINATION WITH BENDAMUSTINE + OBINUTUZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA (CITADEL-102). (23rd June 2022) Authors: Hamadani, M.; Coleman, M.; Boccia, R.; Duras, J.; Hutchings, M.; Zinzani, P. L.; Cordoba, R.; Oreiro, M. B.; Williams, V.; Stouffs, M.; Langmuir, P.; Sancho, J.-M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 994 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗